UBS Group
GOCO

UBS Group’s GoHealth GOCO Stock Holding History

UBS Group’s Portfolio GOCO Stock Details GOCO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-35,614
Closed -$53.8K – 10664
2026
Q1 		$53.8K Sell
35,614
-9,957
-22% -$19K ﹤0.01% 7323
2025
Q4 		$98K Buy
45,571
+42,163
+1,237% +$144K ﹤0.01% 6921
2025
Q3 		$16.4K Buy
3,408
+1,596
+88% +$8.71K ﹤0.01% 8280
2025
Q2 		$10.1K Sell
1,812
-568
-24% -$4.49K ﹤0.01% 8862
2025
Q1 		$29.2K Sell
2,380
-2,878
-55% -$43.9K ﹤0.01% 7966
2024
Q4 		$70.4K Buy
5,258
+660
+14% +$7.51K ﹤0.01% 7079
2024
Q3 		$43.1K Sell
4,598
-17,971
-80% -$182K ﹤0.01% 6912
2024
Q2 		$219K Buy
22,569
+17,800
+373% +$176K ﹤0.01% 5597
2024
Q1 		$50.1K Buy
4,769
+114
+2% +$1.41K ﹤0.01% 6503
2023
Q4 		$62.1K Buy
4,655
+2,623
+129% +$35.9K ﹤0.01% 6431
2023
Q3 		$29.4K Sell
2,032
-2,369
-54% -$40.8K ﹤0.01% 6596
2023
Q2 		$86.7K Buy
+4,401
New +$69.1K ﹤0.01% 6127
2023
Q1 		– Sell
-1,871
Closed -$19.6K – 9875
2022
Q4 		$19.6K Sell
1,871
-404
-18% -$3.59K ﹤0.01% 7673
2022
Q3 		$12K Buy
2,275
+1,808
+387% +$13.6K ﹤0.01% 8158
2022
Q2 		$4K Sell
467
-1,238
-73% -$14.4K ﹤0.01% 9068
2022
Q1 		$30K Sell
1,705
-999
-37% -$31.1K ﹤0.01% 6999
2021
Q4 		$155K Buy
2,704
+637
+31% +$42.5K ﹤0.01% 5910
2021
Q3 		$156K Buy
2,067
+84
+4% +$8.89K ﹤0.01% 5509
2021
Q2 		$334K Sell
1,983
-19
-0.9% -$3.33K ﹤0.01% 5012
2021
Q1 		$351K Sell
2,002
-93
-4% -$18.8K ﹤0.01% 5114
2020
Q4 		$429K Sell
2,095
-435
-17% -$80.8K ﹤0.01% 4717
2020
Q3 		$494K Buy
+2,530
New +$609K ﹤0.01% 4214

Other funds holding GOCO

Barclays
Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return
EF
Empowered Funds Havertown, Pennsylvania $19B AUM 51.73% 1-Year Est. Return
NEWAS
N.E.W. Advisory Services De Pere, Wisconsin $1.5B AUM 19.48% 1-Year Est. Return
GBT
Grove Bank & Trust Miami, Florida $1.01B AUM 26.88% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

UBS Group's GOCO Position: Q2 2026 in Review

UBS Group sold out of GoHealth (GOCO) in Q2 2026, closing a stake of 35,614 shares — an estimated $53.8K sold.

UBS Group first reported a position in GOCO in Q3 2020 and held it in 22 quarters. The position peaked at $494K in Q3 2020. 5 funds tracked by Wall St. Rank hold GOCO as of Q2 2026.

  • UBS Group reported no remaining GoHealth position as of Q2 2026 after selling out during the quarter.
  • UBS Group sold 35,614 GoHealth shares in Q2 2026, an estimated $53.8K.
  • UBS Group first reported a position in GoHealth in Q3 2020 and held it in 22 quarters.
  • UBS Group's GoHealth position peaked at $494K in Q3 2020.
  • 5 funds tracked by Wall St. Rank held GoHealth as of Q2 2026.

Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.